Page 125 - Read Online

Feuer et al. J Cancer Metastasis Treat 2021;7:68 https://dx.doi.org/10.20517/2394-4722.2021.164 Page 11 of 12

4. Zaid HB, Parker WP, Safdar NS, et al. Outcomes following complete surgical metastasectomy for patients with metastatic renal cell
carcinoma: a systematic review and meta-analysis. J Urol 2017;197:44-9. DOI PubMed
5. Soares A, Monteiro FSM, Maluf FC, et al. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from
the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG). J Cancer Res
Clin Oncol 2020;146:1829-45. DOI PubMed PMC
6. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol
1998;16:2261-6. DOI PubMed
7. der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. Metastasectomy in renal cell carcinoma: a multicenter
retrospective analysis. Eur Urol 1999;35:197-203. DOI PubMed
8. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple
metastases from renal cell carcinoma. Cancer 2011;117:2873-82. DOI PubMed
9. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance.
AJR Am J Roentgenol 2008;191:1220-32. DOI PubMed
10. Vikram R, Beland MD, Blaufox MD, et al. ACR appropriateness criteria renal cell carcinoma staging. J Am Coll Radiol 2016;13:518-
25. DOI PubMed
11. Win AZ, Aparici CM. Clinical effectiveness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in
management of renal cell carcinoma: a single institution experience. World J Nucl Med 2015;14:36-40. DOI PubMed PMC
89 18
12. Verhoeff SR, van Es SC, Boon E, et al. Lesion detection by [ Zr]Zr-DFO-girentuximab and [ F]FDG-PET/CT in patients with newly
diagnosed metastatic renal cell carcinoma. Eur J Nucl Med Mol Imaging 2019;46:1931-9. DOI
13. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H. Prognostic factors for survival after pulmonary resection of
metastatic renal cell carcinoma. Ann Thorac Surg 2002;74:1653-7. DOI PubMed
14. Bölükbas S, Kudelin N, Eberlein M, Fisseler-Eckhoff A, Schirren J. The influence of the primary tumor on the long-term results of
pulmonary metastasectomy for metastatic renal cell carcinoma. Thorac Cardiovasc Surg 2012;60:390-7. DOI PubMed
15. Kudelin N, Bölükbas S, Eberlein M, Schirren J. Metastasectomy with standardized lymph node dissection for metastatic renal cell
carcinoma: an 11-year single-center experience. Ann Thorac Surg 2013;96:265-70: discussion 270-1. DOI PubMed
16. Saricam M. Factors affecting long-term survival following pulmonary metastasectomy of renal cell carcinoma. Urol J 2020;17:492-6.
DOI PubMed
17. Kume H, Kakutani S, Yamada Y, et al. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term
survivors? J Urol 2011;185:1611-4. DOI PubMed
18. Huang Z, Du Y, Zhang X, Liu H, Liu S, Xu T. Clear cell renal cell carcinoma bone metastasis: what should be considered in
prognostic evaluation. Eur J Surg Oncol 2019;45:1246-52. DOI PubMed
19. Kollender Y, Bickels J, Price WM, et al. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J
Urol 2000;164:1505-8. PubMed
20. Higuchi T, Yamamoto N, Hayashi K, et al. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases
from renal cell carcinoma. Bone Joint J 2018;100-B:1241-8. DOI PubMed
21. Lin PP, Mirza AN, Lewis VO, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg
Am 2007;89:1794-801. DOI PubMed
22. Ptashnikov D, Zaborovskii N, Kostrickii S, et al. Metastasectomy and targeted therapy for patients with spinal metastases of renal cell
carcinoma. Int J Spine Surg 2020;14:982-8. DOI PubMed PMC
23. Amini A, Altoos B, Bourlon MT, et al. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body
radiation therapy: Is RCC truly radioresistant? Pract Radiat Oncol 2015;5:e589-96. DOI PubMed PMC
24. Jhaveri PM, Teh BS, Paulino AC, et al. A dose-response relationship for time to bone pain resolution after stereotactic body
radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol 2012;51:584-8. DOI PubMed
25. Martel G, Bertens KA, Canil C. Surgical management of genitourinary cancer liver metastases. Surg Oncol Clin N Am 2021;30:89-
102. DOI PubMed
26. Ruys AT, Tanis PJ, Nagtegaal ID, et al. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg
Oncol 2011;18:1932-8. DOI PubMed PMC
27. Staehler MD, Kruse J, Haseke N, et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results
from a retrospective comparative analysis. World J Urol 2010;28:543-7. DOI PubMed
28. Joyce DD, Psutka SP, Groeschl RT, et al. Complications and outcomes associated with surgical management of renal cell carcinoma
involving the liver: a matched cohort study. Urology 2017;99:155-61. DOI PubMed
29. Wroński M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology
1996;47:187-93. DOI PubMed
30. Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011;60:1212-20. DOI PubMed
31. Blom JH, van Poppel H, Maréchal JM, et al; EORTC Genitourinary Tract Cancer Group. Radical nephrectomy with and without
lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3
trial 30881. Eur Urol 2009;55:28-34. DOI PubMed
32. Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol
2003;169:2076-83. DOI PubMed
33. Feuerstein MA, Kent M, Bernstein M, Russo P. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis. Int
J Urol 2014;21:874-9. DOI PubMed PMC